It combines two well-studied appetite and metabolism targets: amylin signaling (cagrilintide, a longacting amylin analogue) and GLP1 signaling (semaglutide, a GLP1 receptor agonist)
Epithalon directly stimulates the cells in the body to produce telomerase enzyme
Ideal sites include the abdomen (staying at least two inches away from the navel), the outer thighs, the back of the upper arms, and the upper buttocks
Users describe it as sustained, clean energy that makes exercise feel easier and daily tasks less draining
Therefore, it is biologically plausible that a person losing significant fat with medication could experience the same redistribution of fat-stored compounds observed with other forms of weight loss
If we can actually get this drug into our patients, we are going to see an even more profound reduction in the epidemiology of CKD that was kick-started by RAS inhibitors 2 decades ago and amplified by flozination in the last few years.